Home/ Supplements/ Vitamin K/ PM Formula

PM Formula

product on market Tablet or Pill TriVita Safety: 90/100
90/100

This product looks safe

  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 70% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains calcium and phosphorus for bone health, alongside vitamin K, B6, and folate for metabolic support. Research evidence for these nutrients is generally strong, though the specific combination in this product has limited clinical coverage. The profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for PM Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
70%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

80 mcg (100% DV)
Within RDA (0.7× RDA) 275 studies (A:9, B:175)
0.5 mg (25% DV)
Within RDA (0.4× RDA) 114 studies (A:3, B:35)
200 mcg (50% DV)
Within RDA (0.5× RDA) 226 studies (A:10, B:105)
Calcium
200 mg (20% DV)
50 mg (5% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
100 mg (25% DV)
Within RDA (0.2× RDA) 316 studies (A:8, B:159)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
100 mcg (143% DV)
1.8× RDA — within safe limits 173 studies (A:0, B:67)
0.75 mg (38% DV)
Within RDA (0.8× RDA) 37 studies (A:0, B:11)
100 mcg (83% DV)
2.9× RDA — within safe limits 199 studies (A:1, B:55)
Market median: 500.0mg (180 products) 5 studies (A:0, B:1)
Within RDA (0.5× RDA) 38 studies (A:1, B:7)
Proprietary blend of 25 whole food concentrates
300 mg
60 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
Market median: 200.0mg (198 products) 6 studies — no high-quality reviews
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Marine Lipid concentrate
33.33 mg
17.3 mg
Market median: 333.0mg (166 products) 9 studies (A:0, B:2)
Butcher's broom
10.6 mg
Trace minerals complex
10 mg

Other Ingredients

Microcrystalline Cellulose Croscarmellose Sodium Stearic Acid Magnesium Stearate Silica film coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: (Note: This is a two part nutritional supplement.) Take 2 PM tablets every evening daily.

Warnings & Precautions

Children, women who are pregnant or nursing, and all individuals allergic to any foods or ingredients should consult their healthcare provider before using this product. You should not stop taking any medication without first consulting with a healthcare provider.

Do not use if seal is broken.

Formulation Notes

Contains milk, wheat, fish (herring, mackerel, sardine, tuna, and cod)

Additional Information

TRIVITA(R) experience wellness

Store in a cool, dry place.

PHYSICIAN APPROVED FORMULA

Item 30200 L 1005-01

Essential Daily Multi-Vitamin Complex with Whole Fruit & Vegetable Concentrates

Metadata

Product Details

DSLD Entry Date2013-02-25
Product TypeOther Combinations
FormTablet or Pill
BrandTriVita
DSLD ID11477
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.